Similarly, NCAPH can be used as a prognostic biomarker for non-small cell lung cancer, lung adenocarcinoma, nasopharyngeal carcinoma, breast cancer, and hepatocellular carcinoma [22–26]. The gene discussed is NCAPH; the disease is nasopharyngeal carcinoma.